Daiwa Securities Group’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-277
| Closed | -$1K | – | 1260 |
|
|
2025
Q4 | $1K | Hold |
277
| – | – | ﹤0.01% | 1344 |
|
|
2025
Q3 | $1K | Hold |
277
| – | – | ﹤0.01% | 1306 |
|
|
2025
Q2 | $1K | Hold |
277
| – | – | ﹤0.01% | 1256 |
|
|
2025
Q1 | $0 | Hold |
277
| – | – | ﹤0.01% | 1289 |
|
|
2024
Q4 | $0 | Hold |
277
| – | – | ﹤0.01% | 1295 |
|
|
2024
Q3 | $1K | Hold |
277
| – | – | ﹤0.01% | 1247 |
|
|
2024
Q2 | $1K | Sell |
277
-6,913
| -96% | -$39K | ﹤0.01% | 1285 |
|
|
2024
Q1 | $53K | Sell |
7,190
-452
| -6% | -$3.76K | ﹤0.01% | 1105 |
|
|
2023
Q4 | $77K | Sell |
7,642
-680
| -8% | -$5.97K | ﹤0.01% | 1047 |
|
|
2023
Q3 | $65K | Hold |
8,322
| – | – | ﹤0.01% | 1048 |
|
|
2023
Q2 | $68K | Buy |
8,322
+8,045
| +2,904% | +$70.1K | ﹤0.01% | 1055 |
|
|
2023
Q1 | $2K | Hold |
277
| – | – | ﹤0.01% | 1211 |
|
|
2022
Q4 | $2K | Buy |
277
+77
| +39% | +$845 | ﹤0.01% | 1220 |
|
|
2022
Q3 | $2K | Hold |
200
| – | – | ﹤0.01% | 1225 |
|
|
2022
Q2 | $2K | Hold |
200
| – | – | ﹤0.01% | 1232 |
|
|
2022
Q1 | $4K | Hold |
200
| – | – | ﹤0.01% | 1190 |
|
|
2021
Q4 | $5K | Sell |
200
-34
| -15% | -$1.17K | ﹤0.01% | 1194 |
|
|
2021
Q3 | $10K | Buy |
234
+101
| +76% | +$5.53K | ﹤0.01% | 1140 |
|
|
2021
Q2 | $8K | Hold |
133
| – | – | ﹤0.01% | 1052 |
|
|
2021
Q1 | $6K | Buy |
133
+16
| +14% | +$912 | ﹤0.01% | 1068 |
|
|
2020
Q4 | $8K | Sell |
117
-187
| -62% | -$7.68K | ﹤0.01% | 1027 |
|
|
2020
Q3 | $9K | Hold |
304
| – | – | ﹤0.01% | 1044 |
|
|
2020
Q2 | $6K | Hold |
304
| – | – | ﹤0.01% | 1097 |
|
|
2020
Q1 | $6K | Hold |
304
| – | – | ﹤0.01% | 1090 |
|
|
2019
Q4 | $9K | Hold |
304
| – | – | ﹤0.01% | 1073 |
|
|
2019
Q3 | $7K | Hold |
304
| – | – | ﹤0.01% | 1051 |
|
|
2019
Q2 | $8K | Hold |
304
| – | – | ﹤0.01% | 1063 |
|
|
2019
Q1 | $7K | Buy |
304
+71
| +30% | +$1.61K | ﹤0.01% | 1052 |
|
|
2018
Q4 | $5K | Hold |
233
| – | – | ﹤0.01% | 1053 |
|
|
2018
Q3 | $7K | Hold |
233
| – | – | ﹤0.01% | 1063 |
|
|
2018
Q2 | $8K | Hold |
233
| – | – | ﹤0.01% | 1066 |
|
|
2018
Q1 | $8K | Buy |
+233
| New | +$8.3K | ﹤0.01% | 1046 |
|
Other funds holding EDIT
VCM
VPM
N
OM
Daiwa Securities Group's EDIT Position: Q1 2026 in Review
Daiwa Securities Group sold out of Editas Medicine (EDIT) in Q1 2026, closing a stake of 277 shares — an estimated $1K sold.
Daiwa Securities Group first reported a position in EDIT in Q1 2018 and held it in 32 quarters. The position peaked at $77K in Q4 2023. 207 funds tracked by Wall St. Rank hold EDIT as of Q1 2026.
- Daiwa Securities Group reported no remaining Editas Medicine position as of Q1 2026 after selling out during the quarter.
- Daiwa Securities Group sold 277 Editas Medicine shares in Q1 2026, an estimated $1K.
- Daiwa Securities Group first reported a position in Editas Medicine in Q1 2018 and held it in 32 quarters.
- Daiwa Securities Group's Editas Medicine position peaked at $77K in Q4 2023.
- 207 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2026.
Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.